Automated Method Development of Oligonucleotide in Tissues Using Clarity OTX 96-Well Plate and High Resolution Mass Spectrometry (TN-0097)
- Abstract:
- As synthetic oligonucleotide (oligo) therapeutics move through the drug-development path, there has been an increasing need for TK and PK/PD studies in drug discovery and development. Because of the specificity, sensitivity, and shorter method development time which they afford, LC/MS/MS methods are preferred over ligand binding assays or ELISA. However, isolation of the oligonucleotide is required prior to analysis via LC/MS/MS; the clean and efficient extraction of synthetic oligonucleotides often proves challenging during method development (MD) due to low sample concentration, analyte recovery, and the possible co-extraction of matrix interferences.
- Document Type:
- Technical Notes
- Industries:
- Pharmaceutical/Biopharmaceutical Life Science
- Techniques:
- HPLC / UHPLC Oligonucleotides Sample Prep
- Brands:
- Clarity Clarity (SPE)
- PDF Link:
- Click here